Cardiac infarction followed by ischemic injury is a major cause of death worldwide. Digitalis, the oldest and best characterized heart failure drug, protects against ischemia-reperfusion injury, and it does so through activation of the mitochondrial ATP-sensitive K+ channel (mitoKATp). The central hypothesis of this project is that ouabain-activated signals are relayed to mitochondria, resulting in mitoKATp opening, increased production of reactive oxygen species (ROS) and activation of survival kinases that protect the heart. Our long-term goal is to uncover the mechanisms that regulate digitalis-induced cardioprotection through activation of the Na,K-ATPase / mitoKATp pathway. During this period, we will focus on the mechanism of signal transmission from the sarcolemmal Na,K-ATPase to mitochondria.
Aim 1 will test the hypothesis that digitalis causes formation of functionally active caveolar microdomains (signalosomes) that interact with the mitochondrial outer membrane, leading to mitoKATp opening and inhibition of the mitochondrial permeability transition.
Aim 2 will investigate signalosome recycling and the persistence of signalosome function.
Aim 3 will investigate signalosome assembly and transport using electron microscopy and immunogold labeling.
Aim 4 will investigate key aspects of digitalis protection and signaling in the rabbit heart model, whose cardiac function and digitalis pharmacology are closer to those in human heart. A variety of experimental approaches will be used. Signalosomes will be purified from perfused hearts and tested for functional activity on mitochondria isolated from untreated hearts. Results of these physiological studies will be supported by parallel studies of infarct size on perfused hearts. Purified signalosomes will also be subjected to biochemical and structural analyses to characterize their composition and origin.
A major goal of this research is to discover how to reduce the damage to the heart that occurs after a heart attack. Digitalis, the oldest and best characterized drug for heart failure, protects against this damage, and this proposal seeks to understand how digitalis interacts with the cell to send this protective message to its specific mitochondrial target inside the cell. This understanding can lead to therapeutic interventions that will reduce a major cause of death.
|Alshahrani, Musaed M; Yang, Eunice; Yip, Jana et al. (2014) CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood 124:2431-41|
|Najjar, Sonia M; Russo, Lucia (2014) CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol 36:55-71|
|Gable, Marjorie E; Abdallah, Simon L; Najjar, Sonia M et al. (2014) Digitalis-induced cell signaling by the sodium pump: on the relation of Src to Na(+)/K(+)-ATPase. Biochem Biophys Res Commun 446:1151-4|
|Li, Daxiang; Wu, Jian; Bai, Yan et al. (2014) Isolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac hypertrophy. J Vis Exp :|
|Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita et al. (2013) Expression of mutant ýý1 Na/K-ATPase defective in conformational transition attenuates Src-mediated signal transduction. J Biol Chem 288:5803-14|
|Bai, Yan; Morgan, Eric E; Giovannucci, David R et al. (2013) Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy. Am J Physiol Heart Circ Physiol 304:H427-35|
|Belliard, Aude; Sottejeau, Yoann; Duan, Qiming et al. (2013) Modulation of cardiac Na+,K+-ATPase cell surface abundance by simulated ischemia-reperfusion and ouabain preconditioning. Am J Physiol Heart Circ Physiol 304:H94-103|
|Najjar, Sonia M; Ledford, Kelly J; Abdallah, Simon L et al. (2013) Ceacam1 deletion causes vascular alterations in large vessels. Am J Physiol Endocrinol Metab 305:E519-29|
|Garlid, Keith D; Halestrap, Andrew P (2012) The mitochondrial K(ATP) channel--fact or fiction? J Mol Cell Cardiol 52:578-83|
|Liu, Changxuan; Bai, Yan; Chen, Yiliang et al. (2012) Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis. J Biol Chem 287:16390-8|
Showing the most recent 10 out of 233 publications